A Phase IIa Study of Intravenous Rituximab in Pediatric Participants With Severe Granulomatosis With Polyangiitis (Wegener's) or Microscopic Polyangiitis
Clinical trial NCT01750697 · COMPLETED
Trial details
- NCT number
- NCT01750697
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-05-23
- Primary completion
- 2018-05-10
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.